にきび治療薬の世界市場：SWOT分析、市場シェア・課題・機会、主要市場セグメント、将来需要・予測（2026年まで）

世界のにきび治療薬の市場規模は、2019年に34億3,800万米ドルと評価され、2021年から2026年の間に3.61％のCAGRで拡大し、2026年末までに41億9,200万米ドルに達すると予想されています。

当レポートでは、世界のにきび治療薬市場について調査し、市場の概要、COVID-19が及ぼす影響、セグメント別による市場分析と予測、地域・国別による予測、および主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 レポート概要

• 調査範囲
• 主要な市場セグメント
• 対象企業：収益別ランキング
• タイプ別の市場分析
  • タイプ別市場規模の成長率：2020年と2026年
  • OTC
  • 処方薬
• アプリケーション別市場
  • アプリケーション別市場シェア：2020 年と2026年
  • 局所
  • 経口
• 調査目的
• 調査機関
• 世界市場の成長に深刻な影響を与える新型コロナウィルス感染症（Covid-19）の影響
  • Covid-19の影響：世界のGDP成長率、2019年、2020年、2021年の予測
  • Covid-19の影響：商品価格指数
  • Covid-19の影響：世界の主要政府の政策

第2章 世界の成長動向

• 世界市場の展望（2015年～2026年）
• 地域別の成長動向
  • 地域別市場規模：2015年、2020年、2026年
  • 地域別市場規模（2015年～2020年）
  • 地域別市場規模予測（2021年～2026年）
• 業界動向と成長戦略
  • 市場の主要動向
  • 市場の成長要因
  • 市場の課題
  • ポーターのファイブフォース分析
  • 市場の成長戦略

第3章 競合情勢

• 市場規模別の世界の主要企業
  • 収益別世界の主要企業（2019年～2020年）
  • 企業別収益市場シェア（2019年～2020年）
  • 企業タイプ別市場（大手、準大手、3番手）
• 市場集中度
  • 世界市場の集中度（CR5およびHHI）
  • 2019年の収益別世界のトップ5企業
• 主要企業本社とサービスエリア
• 主要企業の製品ソリューションとサービス
• メーカーの設立日
• 合併・買収、拡張計画

第4章 タイプ別市場分析（2015年～2026年）

• タイプ別市場規模（2015年～2020年）
• タイプ別市場規模予測（2021年～2026年）

第5章 アプリケーション別市場分析（2015年～2026年）

• アプリケーション別市場規模（2015年～2020年）
• アプリケーション別市場規模予測（2021年～2026年）

第6章 北米

• 北米の市場規模（2015年～2026年）
• 北米の主要企業（2019年～2020年）
• タイプ別の北米の市場規模（2015年～2020年）
• アプリケーション別の北米の市場規模（2015年～2020年）

第7章 欧州

• 欧州の市場規模（2015年～2026年）
• 欧州の主要企業（2019年～2020年）
• タイプ別の欧州の市場規模（2015年～2020年）
• アプリケーション別の欧州の市場規模（2015年～2020年）

第8章 日本

• 日本の市場規模（2015年～2026年）
• 日本の主要企業（2019年～2020年）
• タイプ別の日本市場規模（2015年～2020年）
• アプリケーション別の日本市場規模（2015年～2020年）

第9章 中国

• 中国の市場規模（2015年～2026年）
• 中国の主要企業（2019年～2020年）
• タイプ別の中国の市場規模（2015年～2020年）
• アプリケーション別の中国市場規模（2015年～2020年）

第10章 東南アジア

• 東南アジアの市場規模（2015年～2026年）
• 東南アジアの主要企業（2019年～2020年）
• タイプ別の東南アジア市場規模（2015年～2020年）
• アプリケーション別の東南アジア市場規模（2015年～2020年）

第11章 インド

• インドの市場規模（2015年～2026年）
• インドの主要企業（2019年～2020年）
• タイプ別のインドの市場規模（2015年～2020年）
• アプリケーション別のインドの市場規模（2015年～2020年）

第12章 中南米

• 中南米の市場規模（2015年～2026年）
• 中南米の主要企業（2019年～2020年）
• タイプ別の中南米の市場規模（2015年～2020年）
• アプリケーション別の中南米の市場規模（2015年～2020年）

第13章 主要企業のプロファイル

• Galderma
• Bausch Health
• Teva
• GlaxoSmithKline
• Mylan
• Almirall
• Sun Pharma
• Mayne Pharma
• ライオン
• HUAPONT
• Sine Pharma

第14章 アナリストの見解/結論

第15章 付録

List of Tables and Figures

• Table 1. Acne Medicine Key Market Segments
• Table 2. Key Players Covered: Ranking by Acne Medicine Revenue
• Table 3. Ranking of Global Top Acne Medicine Manufacturers by Revenue (US$ Million) in 2019
• Table 4. Global Acne Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
• Table 5. Global Acne Medicine Market Size Growth by Application (US$ Million): 2020 VS 2026
• Table 6. Overview of the World Economic Outlook Projections
• Table 7. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
• Table 8. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
• Table 9. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
• Table 10. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
• Table 11. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
• Table 12. Covid-19 Impact: Global Major Government Policy
• Table 13. Global Acne Medicine Market Size by Regions (US$ Million): 2015 VS 2020 VS 2026
• Table 14. Global Acne Medicine Market Size by Regions (2015-2020) (US$ Million)
• Table 15. Global Acne Medicine Market Share by Regions (2015-2020)
• Table 16. Global Acne Medicine Forecasted Market Size by Regions (2021-2026) (US$ Million)
• Table 17. Global Acne Medicine Market Share by Regions (2021-2026)
• Table 18. Market Top Trends
• Table 19. Key Drivers: Impact Analysis
• Table 20. Key Challenges
• Table 21. Acne Medicine Market Growth Strategy
• Table 22. Global Acne Medicine Revenue by Players (2019-2020) (US$ Million)
• Table 23. Global Acne Medicine Market Share by Players (2019-2020)
• Table 24. Global Top Acne Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acne Medicine as of 2019)
• Table 25. Global 5 Largest Players Market Share by Acne Medicine Revenue (CR5 and HHI) (2019-2020)
• Table 26. Key Players Headquarters and Area Served
• Table 27. Key Players Acne Medicine Product Solution and Service
• Table 28. Founded Date of Acne Medicine Manufacturers
• Table 29. Mergers & Acquisitions, Expansion Plans
• Table 30. Global Acne Medicine Market Size by Type (2015-2020) (US$ Million)
• Table 31. Global Acne Medicine Revenue Market Share by Type (2015-2020)
• Table 32. Global Acne Medicine Forecasted Market Size by Type (2021-2026) (US$ Million)
• Table 33. Global Acne Medicine Revenue Market Share by Type (2021-2026)
• Table 34. Global Acne Medicine Market Size by Application (2015-2020) (US$ Million)
• Table 35. Global Acne Medicine Revenue Market Share by Application (2015-2020)
• Table 36. Global Acne Medicine Forecasted Market Size by Application (2021-2026) (US$ Million)
• Table 37. Global Acne Medicine Revenue Market Share by Application (2021-2026)
• Table 38. North America Key Players Acne Medicine Revenue (2019-2020) (US$ Million)
• Table 39. North America Key Players Acne Medicine Market Share (2019-2020)
• Table 40. North America Acne Medicine Market Size by Type (2015-2020) (US$ Million)
• Table 41. North America Acne Medicine Market Share by Type (2015-2020)
• Table 42. North America Acne Medicine Market Size by Application (2015-2020) (US$ Million)
• Table 43. North America Acne Medicine Market Share by Application (2015-2020)
• Table 44. Europe Key Players Acne Medicine Revenue (2019-2020) (US$ Million)
• Table 45. Europe Key Players Acne Medicine Market Share (2019-2020)
• Table 46. Europe Acne Medicine Market Size by Type (2015-2020) (US$ Million)
• Table 47. Europe Acne Medicine Market Share by Type (2015-2020)
• Table 48. Europe Acne Medicine Market Size by Application (2015-2020) (US$ Million)
• Table 49. Europe Acne Medicine Market Share by Application (2015-2020)
• Table 50. Japan Key Players Acne Medicine Revenue (2019-2020) (US$ Million)
• Table 51. Japan Key Players Acne Medicine Market Share (2019-2020)
• Table 52. Japan Acne Medicine Market Size by Type (2015-2020) (US$ Million)
• Table 53. Japan Acne Medicine Market Share by Type (2015-2020)
• Table 54. Japan Acne Medicine Market Size by Application (2015-2020) (US$ Million)
• Table 55. Japan Acne Medicine Market Share by Application (2015-2020)
• Table 56. China Key Players Acne Medicine Revenue (2019-2020) (US$ Million)
• Table 57. China Key Players Acne Medicine Market Share (2019-2020)
• Table 58. China Acne Medicine Market Size by Type (2015-2020) (US$ Million)
• Table 59. China Acne Medicine Market Share by Type (2015-2020)
• Table 60. China Acne Medicine Market Size by Application (2015-2020) (US$ Million)
• Table 61. China Acne Medicine Market Share by Application (2015-2020)
• Table 62. Southeast Asia Key Players Acne Medicine Revenue (2019-2020) (US$ Million)
• Table 63. Southeast Asia Key Players Acne Medicine Market Share (2019-2020)
• Table 64. Southeast Asia Acne Medicine Market Size by Type (2015-2020) (US$ Million)
• Table 65. Southeast Asia Acne Medicine Market Share by Type (2015-2020)
• Table 66. Southeast Asia Acne Medicine Market Size by Application (2015-2020) (US$ Million)
• Table 67. Southeast Asia Acne Medicine Market Share by Application (2015-2020)
• Table 68. India Key Players Acne Medicine Revenue (2019-2020) (US$ Million)
• Table 69. India Key Players Acne Medicine Market Share (2019-2020)
• Table 70. India Acne Medicine Market Size by Type (2015-2020) (US$ Million)
• Table 71. India Acne Medicine Market Share by Type (2015-2020)
• Table 72. India Acne Medicine Market Size by Application (2015-2020) (US$ Million)
• Table 73. India Acne Medicine Market Share by Application (2015-2020)
• Table 74. Central & South America Key Players Acne Medicine Revenue (2019-2020) (US$ Million)
• Table 75. Central & South America Key Players Acne Medicine Market Share (2019-2020)
• Table 76. Central & South America Acne Medicine Market Size by Type (2015-2020) (US$ Million)
• Table 77. Central & South America Acne Medicine Market Share by Type (2015-2020)
• Table 78. Central & South America Acne Medicine Market Size by Application (2015-2020) (US$ Million)
• Table 79. Central & South America Acne Medicine Market Share by Application (2015-2020)
• Table 80. Galderma Company Details
• Table 81. Galderma Business Overview
• Table 82. Galderma Acne Medicine Product
• Table 83. Galderma Revenue in Acne Medicine Business (2019-2020) (US$ Million)
• Table 84. Galderma Recent Development
• Table 85. Bausch Health Company Details
• Table 86. Bausch Health Business Overview
• Table 87. Bausch Health Acne Medicine Product
• Table 88. Bausch Health Revenue in Acne Medicine Business (2019-2020) (US$ Million)
• Table 89. Bausch Health Recent Development
• Table 90. Teva Company Details
• Table 91. Teva Business Overview
• Table 92. Teva Acne Medicine Product
• Table 93. Teva Revenue in Acne Medicine Business (2019-2020) (US$ Million)
• Table 94. Teva Recent Development
• Table 95. GlaxoSmithKline Company Details
• Table 96. GlaxoSmithKline Business Overview
• Table 97. GlaxoSmithKline Acne Medicine Product
• Table 98. GlaxoSmithKline Revenue in Acne Medicine Business (2019-2020) (US$ Million)
• Table 99. GlaxoSmithKline Recent Development
• Table 100. Mylan Company Details
• Table 101. Mylan Business Overview
• Table 102. Mylan Revenue in Acne Medicine Business (2019-2020) (US$ Million)
• Table 103. Mylan Recent Development
• Table 104. Almirall Company Details
• Table 105. Almirall Business Overview
• Table 106. Almirall Acne Medicine Product
• Table 107. Almirall Revenue in Acne Medicine Business (2019-2020) (US$ Million)
• Table 108. Almirall Recent Development
• Table 109. Sun Pharma Company Details
• Table 110. Sun Pharma Business Overview
• Table 111. Sun Pharma Revenue in Acne Medicine Business (2019-2020) (US$ Million)
• Table 112. Sun Pharma Recent Development
• Table 113. Mayne Pharma Company Details
• Table 114. Mayne Pharma Business Overview
• Table 115. Mayne Pharma Acne Medicine Product
• Table 116. Mayne Pharma Revenue in Acne Medicine Business (2019-2020) (US$ Million)
• Table 117. Mayne Pharma Recent Development
• Table 118. Lion Company Details
• Table 119. Lion Business Overview
• Table 120. Lion Acne Medicine Product
• Table 121. Lion Revenue in Acne Medicine Business (2019-2020) (US$ Million)
• Table 122. HUAPONT Company Details
• Table 123. HUAPONT Business Overview
• Table 124. HUAPONT Acne Medicine Product
• Table 125. HUAPONT Revenue in Acne Medicine Business (2019-2020) (US$ Million)
• Table 126. Sine Pharma Company Details
• Table 127. Sine Pharma Business Overview
• Table 128. Sine Pharma Revenue in Acne Medicine Business (2019-2020) (US$ Million)
• Table 129. Sine Pharma Recent Development
• Table 130. Research Programs/Design for This Report
• Table 131. Key Data Information from Secondary Sources
• Table 132. Key Data Information from Primary Sources
• Figure 1. Global Acne Medicine Market Share by Type: 2020
• Figure 2. Global Acne Medicine Market Share by Type: 2026
• Figure 3. OTC Features
• Figure 4. Prescription Medicine Features
• Figure 5. Global Acne Medicine Market Share by Application: 2020
• Figure 6. Global Acne Medicine Market Share by Application: 2026
• Figure 7. Topical Case Studies
• Figure 8. Oral Case Studies
• Figure 9. Acne Medicine Report Years Considered
• Figure 10. Commodity Prices-Metals Price Indices
• Figure 11. Commodity Prices- Precious Metal Price Indices
• Figure 12. Commodity Prices- Agricultural Raw Material Price Indices
• Figure 13. Commodity Prices- Food and Beverage Price Indices
• Figure 14. Commodity Prices- Fertilizer Price Indices
• Figure 15. Commodity Prices- Energy Price Indices
• Figure 16. G20+: Economic Policy Responses to COVID-19
• Figure 17. Global Acne Medicine Market Size (Value), (US$ Million), 2015 VS 2020 VS 2026
• Figure 18. Global Acne Medicine Market Size YoY Growth 2015-2026 (US$ Million)
• Figure 19. Global Acne Medicine Market Share by Regions: 2020
• Figure 20. Global Acne Medicine Market Share by Regions: 2026
• Figure 21. Global Acne Medicine Market Share by Regions (2021-2026)
• Figure 22. Porter's Five Forces Analysis
• Figure 23. Global Acne Medicine Market Share by Players in 2019
• Figure 24. The Top 5 Players Market Share by Acne Medicine Revenue in 2019
• Figure 25. North America Acne Medicine Market Size YoY Growth (2015-2026) (US$ Million)
• Figure 26. Europe Acne Medicine Market Size YoY Growth (2015-2026) (US$ Million)
• Figure 27. Japan Acne Medicine Market Size YoY Growth (2015-2026) (US$ Million)
• Figure 28. China Acne Medicine Market Size YoY Growth (2015-2026) (US$ Million)
• Figure 29. Southeast Asia Acne Medicine Market Size YoY Growth (2015-2026) (US$ Million)
• Figure 30. India Acne Medicine Market Size YoY Growth (2015-2026) (US$ Million)
• Figure 31. Central & South America Acne Medicine Market Size YoY Growth (2015-2026) (US$ Million)
• Figure 32. Mylan Acne Medicine Product
• Figure 33. Sun Pharma Acne Medicine Product
• Figure 34. Sine Pharma Acne Medicine Product
• Figure 35. Bottom-up and Top-down Approaches for This Report
• Figure 36. Data Triangulation
• Figure 37. Key Executives Interviewed

Market Analysis and Insights: Global Acne Medicine Market

The global Acne Medicine market was valued at US$ 3438 million in 2019 and it is expected to reach US$ 4192 million by the end of 2026, growing at a CAGR of 3.61% during 2021-2026.

Global Acne Medicine Scope and Market Size

Acne Medicine market is segmented by players, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acne Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Acne Medicine market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyzes the impact of Coronavirus COVID-19 on the Acne Medicine industry.

By Company

• Galderma
• Bausch Health
• Teva
• GlaxoSmithKline
• Mylan
• Almirall
• Sun Pharma
• Mayne Pharma
• Lion
• HUAPONT
• Sine Pharma

Segment by Type

• OTC
• Prescription Medicine

Segment by Application

• Topical
• Oral

By Region

• North America
• Europe
• Japan
• China
• Southeast Asia
• India
• Central & South America

TABLE OF CONTENTS

1 REPORT OVERVIEW

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Acne Medicine Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Acne Medicine Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 OTC
  • 1.4.3 Prescription Medicine
• 1.5 Market by Application
  • 1.5.1 Global Acne Medicine Market Share by Application: 2020 VS 2026
  • 1.5.2 Topical
  • 1.5.3 Oral
• 1.6 Study Objectives
• 1.7 Years Considered
• 1.8 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
  • 1.8.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
  • 1.8.2 Covid-19 Impact: Commodity Prices Indices
  • 1.8.3 Covid-19 Impact: Global Major Government Policy

2 GLOBAL GROWTH TRENDS

• 2.1 Global Acne Medicine Market Perspective (2015-2026)
• 2.2 Acne Medicine Growth Trends by Regions
  • 2.2.1 Acne Medicine Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Acne Medicine Historic Market Size by Regions (2015-2020)
  • 2.2.3 Acne Medicine Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter's Five Forces Analysis
  • 2.3.5 Acne Medicine Market Growth Strategy

3 COMPETITION LANDSCAPE BY KEY PLAYERS

• 3.1 Global Top Acne Medicine Players by Market Size
  • 3.1.1 Global Top Acne Medicine Players by Revenue (2019-2020)
  • 3.1.2 Global Acne Medicine Revenue Market Share by Players (2019-2020)
  • 3.1.3 Global Acne Medicine by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Acne Medicine Market Concentration Ratio
  • 3.2.1 Global Acne Medicine Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 5 Companies by Acne Medicine Revenue in 2019
• 3.3 Acne Medicine Key Players Head office and Area Served
• 3.4 Key Players Acne Medicine Product Solution and Service
• 3.5 Founded Date of Acne Medicine Manufacturers
• 3.6 Mergers & Acquisitions, Expansion Plans

4 ACNE MEDICINE BREAKDOWN DATA BY TYPE (2015-2026)

• 4.1 Global Acne Medicine Historic Market Size by Type (2015-2020)
• 4.2 Global Acne Medicine Forecasted Market Size by Type (2021-2026)

5 ACNE MEDICINE BREAKDOWN DATA BY APPLICATION (2015-2026)

• 5.1 Global Acne Medicine Historic Market Size by Application (2015-2020)
• 5.2 Global Acne Medicine Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

• 6.1 North America Acne Medicine Market Size (2015-2026)
• 6.2 Acne Medicine Key Players in North America (2019-2020)
• 6.3 North America Acne Medicine Market Size by Type (2015-2020)
• 6.4 North America Acne Medicine Market Size by Application (2015-2020)

7 EUROPE

• 7.1 Europe Acne Medicine Market Size (2015-2026)
• 7.2 Acne Medicine Key Players in Europe (2019-2020)
• 7.3 Europe Acne Medicine Market Size by Type (2015-2020)
• 7.4 Europe Acne Medicine Market Size by Application (2015-2020)

8 JAPAN

• 8.1 Japan Acne Medicine Market Size (2015-2026)
• 8.2 Acne Medicine Key Players in Japan (2019-2020)
• 8.3 Japan Acne Medicine Market Size by Type (2015-2020)
• 8.4 Japan Acne Medicine Market Size by Application (2015-2020)

9 CHINA

• 9.1 China Acne Medicine Market Size (2015-2026)
• 9.2 Acne Medicine Key Players in China (2019-2020)
• 9.3 China Acne Medicine Market Size by Type (2015-2020)
• 9.4 China Acne Medicine Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

• 10.1 Southeast Asia Acne Medicine Market Size (2015-2026)
• 10.2 Acne Medicine Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Acne Medicine Market Size by Type (2015-2020)
• 10.4 Southeast Asia Acne Medicine Market Size by Application (2015-2020)

11 INDIA

• 11.1 India Acne Medicine Market Size (2015-2026)
• 11.2 Acne Medicine Key Players in India (2019-2020)
• 11.3 India Acne Medicine Market Size by Type (2015-2020)
• 11.4 India Acne Medicine Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

• 12.1 Central & South America Acne Medicine Market Size (2015-2026)
• 12.2 Acne Medicine Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Acne Medicine Market Size by Type (2015-2020)
• 12.4 Central & South America Acne Medicine Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

• 13.1 Galderma
  • 13.1.1 Galderma Company Details
  • 13.1.2 Galderma Company Description and Business Overview
  • 13.1.3 Galderma Acne Medicine Introduction
  • 13.1.4 Galderma Revenue in Acne Medicine Business (2019-2020)
  • 13.1.5 Galderma Recent Development
• 13.2 Bausch Health
  • 13.2.1 Bausch Health Company Details
  • 13.2.2 Bausch Health Company Description and Business Overview
  • 13.2.3 Bausch Health Acne Medicine Introduction
  • 13.2.4 Bausch Health Revenue in Acne Medicine Business (2019-2020)
  • 13.2.5 Bausch Health Recent Development
• 13.3 Teva
  • 13.3.1 Teva Company Details
  • 13.3.2 Teva Company Description and Business Overview
  • 13.3.3 Teva Acne Medicine Introduction
  • 13.3.4 Teva Revenue in Acne Medicine Business (2019-2020)
  • 13.3.5 Teva Recent Development
• 13.4 GlaxoSmithKline
  • 13.4.1 GlaxoSmithKline Company Details
  • 13.4.2 GlaxoSmithKline Company Description and Business Overview
  • 13.4.3 GlaxoSmithKline Acne Medicine Introduction
  • 13.4.4 GlaxoSmithKline Revenue in Acne Medicine Business (2019-2020)
  • 13.4.5 GlaxoSmithKline Recent Development
• 13.5 Mylan
  • 13.5.1 Mylan Company Details
  • 13.5.2 Mylan Company Description and Business Overview
  • 13.5.3 Mylan Acne Medicine Introduction
  • 13.5.4 Mylan Revenue in Acne Medicine Business (2019-2020)
  • 13.5.5 Mylan Recent Development
• 13.6 Almirall
  • 13.6.1 Almirall Company Details
  • 13.6.2 Almirall Company Description and Business Overview
  • 13.6.3 Almirall Acne Medicine Introduction
  • 13.6.4 Almirall Revenue in Acne Medicine Business (2019-2020)
  • 13.6.5 Almirall Recent Development
• 13.7 Sun Pharma
  • 13.7.1 Sun Pharma Company Details
  • 13.7.2 Sun Pharma Company Description and Business Overview
  • 13.7.3 Sun Pharma Acne Medicine Introduction
  • 13.7.4 Sun Pharma Revenue in Acne Medicine Business (2019-2020)
  • 13.7.5 Sun Pharma Recent Development
• 13.8 Mayne Pharma
  • 13.8.1 Mayne Pharma Company Details
  • 13.8.2 Mayne Pharma Company Description and Business Overview
  • 13.8.3 Mayne Pharma Acne Medicine Introduction
  • 13.8.4 Mayne Pharma Revenue in Acne Medicine Business (2019-2020)
  • 13.8.5 Mayne Pharma Recent Development
• 13.9 Lion
  • 13.9.1 Lion Company Details
  • 13.9.2 Lion Company Description and Business Overview
  • 13.9.3 Lion Acne Medicine Introduction
  • 13.9.4 Lion Revenue in Acne Medicine Business (2019-2020)
• 13.10 HUAPONT
  • 13.10.1 HUAPONT Company Details
  • 13.10.2 HUAPONT Company Description and Business Overview
  • 13.10.3 HUAPONT Acne Medicine Introduction
  • 13.10.4 HUAPONT Revenue in Acne Medicine Business (2019-2020)
• 13.11 Sine Pharma
  • 13.11.1 Sine Pharma Company Details
  • 13.11.2 Sine Pharma Company Description and Business Overview
  • 13.11.3 Sine Pharma Acne Medicine Introduction
  • 13.11.4 Sine Pharma Revenue in Acne Medicine Business (2019-2020)
  • 13.11.5 Sine Pharma Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer
• 15.3 Author Details